Acquired Sales Corp (AQSP) financial statements (2021 and earlier)
Company profile
| Business Address |
4227 HABANA AVENUE JACKSONVILLE, FL 32217 |
| State of Incorp. | NV |
| Fiscal Year End | December 31 |
| SIC | 2833 - Medicinal Chemicals and Botanical Products (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in thousands)
| 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 439 | 4,385 | 1 | 28 | 588 | ||||
| Cash and cash equivalents | 439 | 4,385 | 1 | 28 | 588 | ||||
| Receivables | 1,709 | ||||||||
| Inventory, net of allowances, customer advances and progress billings | 641 | ||||||||
| Inventory | 641 | ||||||||
| Prepaid expense | 455 | 10 | 8 | ||||||
| Intangible current assets | 3 | ||||||||
| Other undisclosed current assets | 17 | 200 | |||||||
| Total current assets: | 3,265 | 4,595 | 1 | 28 | 596 | ||||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 8 | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Inventory, real estate | 200 | ||||||||
| Nontrade receivables | 36 | ||||||||
| Property, plant and equipment | 135 | ||||||||
| Long-term investments and receivables | 25 | 603 | |||||||
| Accounts and financing receivable, after allowance for credit loss | 25 | 603 | |||||||
| Intangible assets, net (including goodwill) | 22,291 | ||||||||
| Goodwill | 22,293 | ||||||||
| Intangible assets, net (excluding goodwill) | (1) | ||||||||
| Other undisclosed noncurrent assets | 1,928 | 1,896 | |||||||
| Total noncurrent assets: | 24,562 | 1,896 | 25 | 638 | |||||
| TOTAL ASSETS: | 27,827 | 6,491 | 1 | 53 | 1,234 | ||||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 639 | 38 | 115 | 106 | 92 | 19 | 224 | ||
| Accounts payable | 38 | 113 | 106 | 92 | 19 | 25 | |||
| Accrued liabilities | 1 | 199 | |||||||
| Employee-related liabilities | 350 | ||||||||
| Interest and dividends payable | 64 | 1 | |||||||
| Other undisclosed accounts payable and accrued liabilities | 224 | ||||||||
| Deferred revenue | 1,096 | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Due to related parties | 224 | 122 | 57 | 111 | |||||
| Other undisclosed current liabilities | 573 | 151 | (310) | ||||||
| Total current liabilities: | 2,309 | 189 | 339 | 228 | 149 | 19 | 25 | ||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 150 | ||||||||
| Long-term debt, excluding current maturities | 150 | ||||||||
| Liabilities, other than long-term debt | 3,750 | ||||||||
| Due to related parties | 3,750 | ||||||||
| Total noncurrent liabilities: | 3,900 | ||||||||
| Total liabilities: | 6,208 | 189 | 339 | 228 | 149 | 19 | 25 | ||
| Stockholders' equity | |||||||||
| Stockholders' equity attributable to parent, including: | 21,619 | 6,301 | (339) | (228) | (148) | 33 | 1,209 | ||
| Preferred stock | 0 | 0 | |||||||
| Common stock | 6 | 3 | 2 | 2 | 2 | 2 | |||
| Treasury stock, value | (34) | ||||||||
| Additional paid in capital | 38,787 | 21,691 | 13,665 | 13,555 | 13,555 | 13,555 | 13,555 | ||
| Accumulated deficit | (17,141) | (15,393) | (14,006) | (13,785) | (13,705) | (13,523) | (12,347) | ||
| Other undisclosed stockholders' equity attributable to parent | 2 | ||||||||
| Total stockholders' equity: | 21,619 | 6,301 | (339) | (228) | (148) | 33 | 1,209 | ||
| TOTAL LIABILITIES AND EQUITY: | 27,827 | 6,491 | 1 | 53 | 1,234 | ||||
Income statement (P&L) ($ in thousands)
| 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 5,344 | 0 | 2 | |||||
| Other income | 0 | 2 | ✕ | |||||
| Cost of revenue | (3,407) | |||||||
| Gross profit: | 1,937 | 0 | 2 | |||||
| Operating expenses | (1,085) | (177) | (71) | (65) | (79) | (1,240) | (311) | |
| Other undisclosed operating loss | (2,370) | (1,086) | ||||||
| Operating loss: | (1,518) | (1,263) | (71) | (65) | (79) | (1,237) | (311) | |
| Nonoperating income (expense) | (16) | 27 | 62 | 36 | ||||
| Investment income, nonoperating | 62 | 36 | ||||||
| Other nonoperating income (expense) | (16) | 27 | ||||||
| Interest and debt expense | 13 | 29 | (39) | |||||
| Loss from continuing operations before equity method investments, income taxes: | (1,522) | (1,207) | (110) | (65) | (79) | (1,176) | (275) | |
| Other undisclosed loss from continuing operations before income taxes | (29) | |||||||
| Loss before gain (loss) on sale of properties: | (1,522) | (1,236) | (110) | (65) | (79) | (1,176) | (275) | |
| Other undisclosed net loss | (110) | (15) | (5,046) | |||||
| Net loss: | (1,522) | (1,236) | (221) | (80) | (79) | (1,176) | (5,321) | |
| Other undisclosed net loss attributable to parent | (13) | (102) | ||||||
| Net loss available to common stockholders, diluted: | (1,535) | (1,236) | (221) | (80) | (182) | (1,176) | (5,321) | |
Comprehensive Income ($ in thousands)
| 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (1,522) | (1,236) | (221) | (80) | (79) | (1,176) | (5,321) | |
| Comprehensive loss, net of tax, attributable to parent: | (1,522) | (1,236) | (221) | (80) | (79) | (1,176) | (5,321) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.